G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 94 filers reported holding G1 THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $214,295 | -74.5% | 39,465 | -41.4% | 0.01% | -80.0% |
| Q3 2022 | $840,000 | +833.3% | 67,293 | +270.3% | 0.03% | +650.0% |
| Q2 2022 | $90,000 | -70.7% | 18,171 | +6.5% | 0.00% | -87.9% |
| Q4 2020 | $307,000 | -65.8% | 17,055 | -78.0% | 0.03% | -43.1% |
| Q3 2020 | $897,000 | +311.5% | 77,670 | +713.5% | 0.06% | +205.3% |
| Q3 2019 | $218,000 | +13.0% | 9,548 | -5.0% | 0.02% | +58.3% |
| Q4 2018 | $193,000 | -72.3% | 10,054 | -24.5% | 0.01% | -76.9% |
| Q3 2018 | $696,000 | – | 13,308 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
| Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
| Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
| 361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
| Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
| CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
| Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
| Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
| Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
| HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |